Unique Antibody Library X-BODY Biosciences stands out with a remarkably diverse DNA-tagged human antibody library, offering potential partners access to unique therapeutic targets not available elsewhere.
Competitive Funding With $2.7 million in funding, X-BODY Biosciences is poised to leverage its financial support to accelerate research and development, making it an attractive partner for collaborations and investments.
Strategic Market Position Despite being a smaller biotech company, X-BODY Biosciences' focused approach to discovering novel biotherapeutic compounds gives it a strategic advantage in identifying untapped market opportunities and potential growth areas.
Niche Biotechnology Research X-BODY Biosciences' niche focus on biotechnology research allows it to offer specialized solutions to pharmaceutical companies and healthcare institutions seeking unique therapeutics that cater to specific unmet medical needs.
Growth Potential As a company with a lean team of 11-50 employees, X-BODY Biosciences presents growth potential, making it an ideal partner for those looking to collaborate with an agile and innovative organization poised for expansion in the biotechnology sector.
51
$10M$50M
537$50M$100M
17$10M$50M
556$100M$1B
70$10M$50M
74$10M
187$10M$50M
205$10M$50M
138$10M$50M| X-BODY Biosciences Email Formats | Percentage |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
Biotechnology Research11-50 Employees
X-BODY is a privately held biotechnology company focused on discovering novel biotherapeutic compounds. The company’s mission is to apply its innovative capabilities and remarkably diverse DNA-tagged human antibody library to the discovery of human antibodies against novel therapeutic targets.
Company Overview
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
1-888-653-2347 
support@leadiq.com